Company intelligence / Profile preview

Sirius Capital

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Sirius Capital is a prominent venture capital and private equity firm based in Shanghai, China, with a specialized focus on the healthcare and life sciences sectors. The firm invests across the entire healthcare value chain, including innovative drug development, medical devices, in vitro diagnostics (IVD), and healthcare services. Sirius Capital typically targets early to growth-stage companies, providing strategic resources and capital to help portfolio companies navigate regulatory and commercial landscapes. Its portfolio includes several notable biotechnology companies involved in oncology, metabolic diseases, and advanced medical technologies.

Industry: Investors

Beyond the preview

Go deeper on Sirius Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sirius Capital.

Explore the full profile